Search for Clinical Trial Results
Glomerulosclerosis, Focal Segmental - 25 Studies Found
Status | Study |
Withdrawn |
Study Name: Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-31 Interventions: Drug: Galactose Oral galactose, 0.2 g/kg/dose twice daily for 28 days |
Recruiting |
Study Name: Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients Condition:
|
Recruiting |
Study Name: A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS Condition: Primary Focal Segmental Glomerulosclerosis Date: 2012-04-05 Interventions: Biological: Rituximab Rituximab will be infused intravenously on Day 1 and Day 15 at a dose of 375 mg/m2 |
Completed |
Study Name: Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) Condition: Glomerulosclerosis, Focal Date: 2005-08-24 Interventions:
|
Recruiting |
Study Name: Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS Condition: Idiopathic Focal Segmental Glomerulosclerosis Date: 2015-12-15 Interventions:
|